Sector: MedicalVION (OTCBB: VION)
Headlines
- Vion Pharmaceuticals Reports 2009 Third Quarter and Nine-Month Results
Nov 10, 2009 04:30 PM | VION
- Vion Pharmaceuticals Engages Merriman Curhan Ford to Evaluate Strategic Alternatives
Oct 12, 2009 04:00 PM | VION
- Skymark Research Initiates Independent Research Coverage On Vion Pharmaceuticals, Inc.
Sep 10, 2009 08:31 AM | VION
- Vion Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference
Sep 09, 2009 08:02 AM | VION
- Clolar Gets Cool Reception From FDA And Up For Approval (GENZ, VION)
Sep 02, 2009 12:09 PM | GENZ, VION
- Vion Pharmaceuticals Announces Results of the Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
Sep 02, 2009 08:01 AM | VION
- FDA Extreme Trades: 16 Stocks Under $5
Jun 27, 2009 04:55 PM | ANPI, APPA, CTIC, DDSS, GSK, HEB
- FDA Calendar Stocks On The Move: DSCO, VION, NFLD
Apr 16, 2009 04:10 PM | DSCO, VION
- Feel Good Friday: Nailing A Perfect Short Sale On Vermillion, Inc. (VRML)
May 11, 2008 01:10 AM | LGDI, REED, VION
- Another Turnaround Tuesday?
Jan 08, 2008 10:37 AM | AAPL, ACGY, AEHR, AKNS, AMZN, BLUD
- Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results
Aug 11, 2009 08:01 AM | VION
- Vion Pharmaceuticals Announces Oncologic Drugs Advisory Committee Meeting for Onrigin(TM)
Aug 10, 2009 12:28 PM | VION
- Vion Pharmaceuticals Presents Data on Onrigin(TM) Elderly AML Trials at the ASCO(R) Annual Meeting
Jun 01, 2009 08:03 AM | VION
- Vion Pharmaceuticals to Present Data on Onrigin(TM)at the ASCO(R) Annual Meeting
May 29, 2009 08:01 AM | VION
- Vion Pharmaceuticals Reports 2009 First Quarter Results
May 11, 2009 04:53 PM | VION
- Vion Pharmaceuticals Receives a Standard Review from the FDA for Its New Drug Application for Onrigin(TM)
Apr 23, 2009 02:36 PM | VION
- Vion Pharmaceuticals' New Drug Application for Onrigin(TM)Accepted For Review by the FDA
Apr 16, 2009 08:02 AM | VION
- Vion Reports 2008 Full-Year and Fourth-Quarter Results
Mar 10, 2009 08:04 AM | VION
- Vion Pharmaceuticals Submits New Drug Application for Onrigin(TM)
Feb 17, 2009 08:05 AM | VION
- Vion Pharmaceuticals Presents Additional Survival Data on Onrigin(TM) (Laromustine) Injection at ASH Annual Meeting
Dec 08, 2008 08:03 AM | VION
- Form 4 Cahill Ann Lee For: Sep 08 (10K)
Sep 10, 2009 03:42 PM
- Form 4 VION PHARMACEUTICALS For: Sep 09 Filed by: KING IVAN (10K)
Sep 10, 2009 03:42 PM
- Form 4 VION PHARMACEUTICALS For: Dec 11 Filed by: RAKIN KEVIN (10K)
Dec 12, 2008 02:05 PM
- Form 4 VION PHARMACEUTICALS For: Dec 11 Filed by: SARTORELLI ALAN (10K)
Dec 12, 2008 02:05 PM
- Form 4 Williams Ian For: Dec 11 (10K)
Dec 12, 2008 02:05 PM
- Form 4 WILLIS GARY K For: Dec 11 (10K)
Dec 12, 2008 02:05 PM
- Form 4 Lewis Tanya For: Dec 10 (10K)
Dec 12, 2008 02:04 PM
- Form 4 Bickerstaff George For: Dec 11 (10K)
Dec 12, 2008 02:04 PM
- Form 4 VION PHARMACEUTICALS For: Dec 11 Filed by: MILLER WILLIAM R (10K)
Dec 12, 2008 02:04 PM
- Form 3 Lewis Tanya For: Dec 01 (10K)
Dec 04, 2008 05:03 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
VION
|
Compare to S&P
|
| YTD |
64.86 %
|
36.45 %
|
| 4 Weeks |
-27.38 %
|
-28.17 %
|
| 12 Weeks |
-83.06 %
|
-84.03 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 6.02 %
|
|
EPS Growth in Last Year: 15.22 %
|
|
Sales Growth in Last Quarter: 0.00 %
|
|
Sales Growth in Last Quarter: -37.50 %
|
|
